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Important set of studies have demonstrated the endocrine disrupting activity of Bisphenol
A (BPA). The present work aimed at defining estrogenic-like activity of several BPA
structural analogs, including BPS, BPF, BPAF, and BPAP, on 4- or 7-day post-fertilization
(dpf) zebrafish larva as an in vivo model. We measured the induction level of the
estrogen-sensitive marker cyp19a1b gene (Aromatase B), expressed in the brain,
using three different in situ/in vivo strategies: (1) Quantification of cyp19a1b transcripts
using RT-qPCR in wild type 7-dpf larva brains exposed to bisphenols; (2) Detection
and distribution of cyp19a1b transcripts using in situ hybridization on 7-dpf brain
sections (hypothalamus); and (3) Quantification of the cyp19a1b promoter activity in live
cyp19a1b-GFP transgenic zebrafish (EASZY assay) at 4-dpf larval stage. These three
different experimental approaches demonstrated that BPS, BPF, or BPAF exposure,
similarly to BPA, significantly activates the expression of the estrogenic marker in the brain
of developing zebrafish. In vitro experiments using both reporter gene assay in a glial cell
context and competitive ligand binding assays strongly suggested that up-regulation of
cyp19a1b is largely mediated by the zebrafish estrogen nuclear receptor alpha (zfERα).
Importantly, and in contrast to other tested bisphenol A analogs, the bisphenol AP (BPAP)
did not show estrogenic activity in our model.
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INTRODUCTION
Estrogens play important roles in many developmental and physiological processes (Boon et al.,
2010) and references therein, including for brain development (Hojo et al., 2008; Hill and Boon,
2009; Bondesson et al., 2014; Coumailleau et al., 2015). Bisphenol A (BPA) is a well-known chemical
compound that mimic and interfere with the actions of endogenous estrogens and thus act as
an endocrine disruptor (Krishnan et al., 1993; Gould et al., 1998; Paris et al., 2002; Kitamura
et al., 2005; Richter et al., 2007; Wetherill et al., 2007; Vogel, 2009; Grignard et al., 2012). BPA
is a chemical used in many industrial and commercial applications including in the production
of polycarbonate plastics and epoxy resins, present in a variety of consumer products such as
food-packaging materials, toys, thermal and recycled papers, compact discs, impact-resistant safety
equipment, and medical devices to name a few (Vinggaard et al., 2000; Vandenberg et al., 2010;
Liao and Kannan, 2011; Staples et al., 2011; Huang et al., 2012; Liao et al., 2012a,c). BPA rapidly
became one of the most produced and used chemicals worldwide (about 3.4 million tons per year).
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The widespread use of BPA has resulted in its detection
in environment (Huang et al., 2012; Liao et al., 2012b), in
food (Schecter et al., 2010; Liao and Kannan, 2013), and in
human biological sample (Sun et al., 2004; Calafat et al., 2005,
2009; Vandenberg et al., 2010; Zalko et al., 2011; Fenichel
et al., 2012; Liao et al., 2012a; Vandenberg et al., 2012).
Epidemiological studies, along with laboratory studies in many
species including primates, provide increasing support that
environmental BPA exposure can be harmful to humans and is
associated with a wide range of effects in humans, rodents, and
wildlife. Indeed, BPA exposure is linked to numerous adverse
health concerns including development, diabetes, obesity,
cardiovascular, reproductive disorders, behavioral troubles,
chronic respiratory and kidney diseases, and carcinogenesis,
likely linked to the endocrine disrupting effects (Vandenberg
et al., 2012; Rochester, 2013; Rezg et al., 2014). Owing those
potential health concerns, Canada (2009), USA (2010), and
the European Union (2011) prohibited the use of BPA in the
manufacture of polycarbonate feeding bootles for infants. In
France, since January 2015, BPA is forbidden in any food or
beverage packaging.
Such restrictions on BPA usage recently led manufactories
to use alternative bisphenols. Such alternatives include among
others bisphenol AF, bisphenol F, and bisphenol S (Liu et al.,
2012). For instance, BPS is found in canned soft drinks, canned
foods (Vinas et al., 2010; Gallart-Ayala et al., 2011) and in thermal
receipt papers (Becerra and Odermatt, 2012; Liao et al., 2012c).
BPAF is also incorporated into the production of fluoropolymers,
fluoroelastomers, and in a variety of polymers that are used
in the manufactoring of electronic devices and plastic optical
fibers (Yang et al., 2012). Recent large-scale quantitative studies
have identified, in addition to BPA, increasing concentrations of
various bisphenols such as BPAF, BPAP, BPF, BPS, BPB, BPZ, and
BPP in food products in the United States (Liao and Kannan,
2013). In addition, BPB, BPF, and BPS were also detected in
indoor dust in the USA and in several Asian countries (Liao
et al., 2012b). However, despite the increasing use of BPA analogs,
there is limited information on potential toxicity and endocrine-
disrupting activities of these molecules. However, few BPA
analogs present some endocrine disrupting activity, as assessed
by in vitro analysis. For instance, it was shown that BPS and BPAF
can bind to estrogen receptors and subsequently exert estrogenic
activity at the transcriptional level using cell culture and binding
assays (Hashimoto et al., 2001; Kitamura et al., 2005; Kuruto-
Niwa et al., 2005; Matsushima et al., 2010; Grignard et al., 2012).
Although the estrogenic potential of few BPA analogs have been
demonstrated in vitro, the in vivo potential endocrine-disrupting
activity of these compounds remains largely unknown. Recent
physiological studies suggest that at least a few BPA analogs
have the potential to interfere and disrupt the normal functions
of endocrine system in various organisms (Feng et al., 2012;
Ji et al., 2013; Naderi et al., 2014; Yang et al., 2014; Eladak
et al., 2015). A growing number of studies have shown that
BPA has a negative impact on neural development and on the
onset of neurological disorders, likely associated to its endocrine-
disrupting activities (reviewed in Kajta and Wojtowicz, 2013;
Leon-Olea et al., 2014; Negri-Cesi, 2015). To our knowledge,
very limited work has assessed estrogenic activity of BPA analogs
during brain development, and/or in adult brain. A recent study
suggests that exposure to BPS might cause hyperactivity and
brain changes in developing zebrafish (Kinch et al., 2015).
In the present study, we assessed the potential in vivo
estrogenic activities of various BPA analogs and their effects on
the central nervous system using the developing zebrafish brain.
The developmental pattern of the zebrafish is particularly well-
studied (Briggs, 2002) and the species is a widely used model
to evaluate the potential adverse effects of chemicals present in
the environment and to define the mechanisms underlying the
endocrine-disrupting activities (Segner, 2009).Indeed, numerous
estrogen-sensitive proteins have been identified in zebrafish,
including the liver-produced yolk proteins Vitellogenin 1 and
3 (encoded by vtg1 and vtg3 genes), and the brain-specific
aromatase B (AroB), encoded by the brain specific cyp19a1b gene,
and change in their expression can be used as biomarker for
estrogen or xenoestrogen exposure (Kausch et al., 2008; Ruggeri
et al., 2008; Levi et al., 2009; Chung et al., 2011; Lam et al., 2011;
Hao et al., 2013). We and others have shown that the cyp19a1b
gene is specifically expressed in a very specific brain population,
the radial glial cells, that serves as progenitors during embryonic
and adult neurogenesis (for review see Diotel et al., 2010;
Coumailleau et al., 2015; Pellegrini et al., 2015). In addition, the
presence of functional estrogen response elements in cyp19a1b
proximal promoter region allows for a strong transcriptional
upregulation by estrogens (E2) and xenoestrogens such as ethinyl
estradiol (EE2) and BPA (Le Page et al., 2006; Sawyer et al., 2006;
Chung et al., 2011; Brion et al., 2012). Thus, the cyp19a1b gene
can be used in vivo as a biomarker of xenoestrogen effects on the
central nervous system in developing and adult zebrafish.
In the present work, we investigated the effects of various BPA
analogs on cyp19a1b expression in developing zebrafish brain
exposed from 0 to 1 day post-fertilization (0–1 dpf) to 4–7 dpf.
We used 3 different in situ/in vivo approaches: (1) quantitative
RT-PCR to monitor the expression levels of cyp19a1b in wild
type larvae (7 dpf); (2) cyp19a1b in situ hybridization to precisely
analyse the induction and distribution of cyp19a1b transcripts in
wild type 7-dpf larvae, and (3) the quantification of the brain
fluorescence of cyp19a1b-GFP transgenic 4-dpf larvae as an in
vivo assay (EASZY assay). We demonstrate that the majority of
the tested bisphenol A analogs (BPS, BPF, and BPAF) induces in
vivo significant expression of cyp19a1b in the brain of zebrafish
at early developmental stages.
MATERIALS AND METHODS
Chemicals
Bisphenol analogs, including bisphenol A [BPA; 2,2-
bis(4-hydroxyphenyl)propane; 99%), bisphenol F [BPF;
4,4′-dihydroxydiphenyl methane; 98%), bisphenol AF [BPAF;
2,2-bis(4-hydroxylphenyl)hexafluoropropane; 98%), bisphenol S
[BPS; bis-(4-hydroxyphenyl)sulfone; 98%), bisphenol AP [BPAP;
4,4′-(1- phenylethylidene)bisphenol; 98%], were purchased from
Sigma-Aldrich (St. Louis, MO) and TCI America (Portland,
OR). E2 [17β-estradiol] and EE2 [17α-ethinylestradiol] were
purchased from Sigma Aldrich (St. Louis, MO, USA). ICI 182
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780 was purchased from Tocris Bioscience. Stock solutions
were prepared in dimethyl sulfoxide (DMSO; Sigma) and kept
at −20◦C. Dilution series were freshly prepared before each
experiment. The maximum volume of the solvent did not exceed
0.1% (v/v).
Zebrafish Maintenance and Embryo/Larva
Exposure
Animals were treated in agreement with the European Union
regulations concerning the protection of experimental animals.
This study was approved by the ethics committee (CREEA:
Comité Rennais d’Ethique en matière d’Expérimentation
Animale) under permit number EEA B-35-040. Zebrafish
embryos were raised in our facilities (IFR 140, INRA SCRIBE,
Rennes, France) in recirculated water kept at 28.5◦C and
spawned under standard conditions. Embryos were collected 2 h
post-fertilization (hpf), and examined under a binoccular. Those
embryos that had developed normally were selected and kept in
several Petri dishes (zebra.s- c.edu/guides.html) in an incubator
at 28.5◦C (kept on a 14-h light, 10-h dark cycle).
For subsequent RT-qPCR and in situ hybridization analysis
with wild type zebrafish, groups of 80 embryos (for each
condition) were placed after 1 day post-fertilization (1-dpf) in
a large glass flask containing 100ml of embryonic medium
(Mouriec et al., 2009b). Chemical treatments were performed
by adding either DMSO alone (negative control), EE2 (positive
control), or one of the tested bisphenols (BPA, BPS, BPF, BPAF,
BPAP) diluted in water at indicated concentrations, thereby
creating 7 experimental treatment conditions. The embryos
were held in the exposure flasks until 7-dpf larva stage. For
studies with the cyp19a1b-GFP transgenic zebrafish line (Tong
et al., 2009; Brion et al., 2012), groups of 20 embryos (for each
condition) were placed 2 h post-fertilization in crystallization
dishes containing 25ml medium and at indicated concentration
of tested bisphenols analogs, EE2, or DMSO. Embryos were
maintained in the exposure dishes until 4-dpf larva stage. During
the treatment period, 100% of the exposure mediumwas renewed
every 24 h (for both wild type and transgenic zebrafish). No
mortality was observed for any treatments during the exposure
period.
Quantitative Real-Time PCR
After exposure, approximately 70 wild type heads were collected
at 7 dpf (i.e., 6 days of exposure) for each experimental
conditions (DMSO, EE2, BPA, BPS, BPF, BPAF, and BPAP)
into 1.5ml Eppendorf tubes, and frozen in liquid nitrogen.
Tissue was sonicated (10 s, 3 times) in 250 µL Trizol
Reagent (Invitrogen) and RNA extractions were carried out
according to the manufacturer’s protocol. Reverse transcription
was carried out by incubating 2µg total RNA with 1µg of
random primer oligonucleotides, 2.5m˙M dNTPs, and 50U
MMLV-RT (Promega) in the appropriate buffer for 10min
at 65◦C and 60min at 37◦C. Quantitative Polymerase chain
reaction (qPCR) experiments were performed in an iCycler
thermocycler coupled to the MyiQ detector (Bio-Rad. Hercules,
CA, USA) using iQ SYBR-Green Supermix (Bio-Rad) according
to the manufacturer’s protocol. The following primers were
used: ef1 (fw) 5′-AGCAGCAGCTGAGGAGTGAT-3′; ef1 (rev)
5′-CCGCATTTGTAGATCAGATGG-3′; cyp19a1b (AroB; fw)
5′-TCGGCACGGCGT- GCAACTAC-3′; cyp19a1b (AroB; rev)
5′-CATACCTATGCATTGCAGACC-3′. For each condition, the
RT-PCR experiment was run in triplicates. Expression levels of
ef1 mRNA were used to normalize cyp19a1b expression levels.
Melting curve and PCR efficiency analyses were performed to
confirm correct amplification. For quantification of PCR results,
the threshold cycle (Ct) was determined for each reaction.
Ct values for each gene of interest were normalized with the
housekeeping gene ef1, using the 11Ct method. Normalized
values were used to calculate the degree of induction or inhibition
expressed as a “fold difference” compared to normalized control
values.
Brain Sections and In situ Hybridization
Larvae used for in situ hybridization experiments originated
from the same exposition groups than RT-qPCR experiments.
After exposure to the different conditions, 10 wild type 7-dpf
larvae (for each treatment) were fixed overnight at 4◦C in
4% paraformaldehyde, before embedding in parrafin. Serial
thin transverse sections (8 µM) were placed on cryofrost
slides and subjected to in situ hybridization experiments. Sense
and antisense digoxigenin-labeled riboprobes for the cyp19a1b
gene were transcribed using the Digoxigenin RNA labeling
kit in accordance with the manufacturer’s instructions (Roche,
Mannheim, Germany) and as previously described (Menuet et al.,
2005). The brain sections were processed for in situ hybridization
using stringent conditions as previously published (D’Amico
et al., 2011, 2013). After NBT/BCIP revelation, sections were
counterstained with DAPI, and mounted in a drop of vectashield
(Vector Laboratories). All sections were photographed with
an Olympus PROVIS AX70 microscope with a digital camera
(Olympus SP71), or a Nikon multizoom AZ100 macroscope with
a DS-Ri1 color camera.
In vivo Imaging with the EASZY Assay
Quantification of fluorescence in transgenic cyp19a1b-GFP
zebrafish larva brain was performed according to Brion
et al. (2012). In this assay, estrogenic activity is detected in
living 4 days-old larvae (treated or not with an estrogen
mimic compound) from the observation of the reporter gene
fluorescence in the radial glial cells. After exposure conditions
(see above), live tg (cyp19a1b-GFP), 4 dpf larvae (20 specimens
per condition) were observed in dorsal view and each specimen
was photographed using a Zeiss AxioImager.Z1 fluorescence
microscope equipped with a AxioCam Mrm camera (Zeiss
GmbH, Göttingen, Germany). All photographs were taken using
the same parameters: only the head was photographed under
a X10 objective, with a 134ms exposure time and maximal
intensity. Photographs were analyzed using the Axiovision
Imaging software and fluorescence quantification was performed
using the ImageJ software (http://rsbweb.nih.gov/ij/). For each
picture, the integrated density was measured, i.e., the sum of
the gray-values of all the pixels within the region of interest.
A gray-value of 290 was defined as background value. For
each micrograph the fluorescence fold induction of fluorescence
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was calculated comparing the integrated pixel density with the
average fluorescence induction obtained in the control group.
Plasmid Constructions
The zfER-α, zfER-β1, and zfER-β2 expression vectors correspond
to Topo-pcDNA3 expression vector (Invitrogen, San Diego, CA,
USA), containing the coding regions of each zebrafish estrogen
receptor cDNA as previously described (Menuet et al., 2002). The
cyp19a1b-Luciferase plasmid consists of 500 bp of the proximal
promoter region of zebrafish cyp19a1b gene, containing an ERE,
coupled to the luciferase reporter gene (Menuet et al., 2002).
Glial Cell Culture and Transfection
Experiments
Human U251-MG glial cells were maintained in phenol red-free
Dulbecco’s Modified Eagle’s Medium (DMEM; Life Technologies,
Saint Aubin, France) supplemented with 10% fetal calf serum
(Biowest, Nuaillé, France), 4mM L-Glutamine (Gibco, Carlsbad,
CA, USA) and 1mM Na-Pyruvate (Life Technologies, Saint
Aubin, France) and kept at 37◦C and 5% CO2 atmosphere (Le
Page et al., 2006). The medium was also supplemented with
20 U/mL penicillin, 20 µg/mL streptomycin, and 50 ng/mL
amphotericin B (Gibco). For transfections, cells were plated
in 24-well plates at a density of 25,000 cells/ml in the same
medium, except the fetal calf serum was charcoal-treated and
used at a concentration of 2.5%. Cells were transfected with
25 ng/well either the vector expression containing or not the
the zfERα, zfERβ1, zfERβ2 coding region and cytomegalovirus
[CMV]−β-Galactosidase, and 150 ng/well of the cyp19a1b-
Luciferase reporter plasmid, using JetPEI as a transfection
reagent (Polyplus Transfection, Illkirch, France). One day after
transfection, U251-MG cells were treated with chemicals using
same concentrations as in vivo experiments (10–9 M and 10–6
M, for EE2 and bisphenols, respectively) and DMSO as a vehicle
(1/10.000). Luciferase activity wasmeasured 24 h later (Luciferase
assay system, Promega, Madison, WI, USA). β-Galactosidase
activity was used to normalize transfection efficiency. Chemicals
were tested in at least 3 independent experiments and each
experiment was performed in triplicate.
Zebrafish Estrogen Receptor
Competitive-Binding Assays
We also performed a competitive binding assay to test the
binding properties of our compounds of interest with the
three zfERs (Blair et al., 2000). The three zebrafish estrogen
receptor proteins were synthesized using the Topo-pcDNA3
expression vector containing the coding region of zfERα, zfERβ1,
and zfERβ2 (Menuet et al., 2002). The TNT Quick Coupled
Transcription/Translation Systems kit (Promega, Madison, WI,
USA) was used for synthesis of zfER proteins by adding 1 µg of
each ER expression vector and according to the manufacturer’s
protocol. Efficiency of translation was assessed by SDS-PAGE
(data not shown). After in vitro synthesis, 5 µl of zfERα, zfERβ1,
or zfERβ2 were incubated overnight at 4◦C with 10−9 M [3H]-E2
in absence or presence of increasing concentrations of radioinert
E2 (10−11 M, 10−10 M, 10−9 M, 10−8 M, 10−7 M), BPA, BPF,
BPS, BPAF, or BPAP (10−10 M, 10−9 M, 10−8 M, 10−7 M, 10−6
M, 10−5 M). The relative binding affinity for each compound
was analyzed by their efficiency to move [3H]-E2 from the zfER
binding site. Results were expressed as a percentage of displaced
[3H]-E2 binding. The 10−7 M E2 containing 100-fold excess of
radioinert E2 compared to [3H]-E2 was considered as the non-
specific binding (Blair et al., 2000). IC50 were calculated using
GraphPad Prism, version 6.07.
RESULTS
In this study, we tested the estrogenic potentials of various
bisphenols (BPA, BPS, BPAF, BPF, and BPAP) using the estrogen
sensitive biomarker cyp19a1b gene in zebrafish brain. Three
different experimental approaches were used to validate our
results: RT-qPCR on whole brain extract and in situ hybridization
on brain sections in wild type zebrafish larvae (7-dpf), and
the EASZY assay on cyp19a1b-GFP zebrafish larvae (4-dpf).
In addition, we performed two in vitro assays including a
transfection experiment in a glial cell context and a competitive
binding assay, in order to identify the nuclear estrogen receptors
mediating up-regulation of the cyp19a1b gene.
Establishment of a Proper BPA
Concentration Inducing cyp19a1b Gene in
the Brain of 7-dpf Zebrafish Larvae
We first performed real-time RT-qPCR to determine the
expression level of cyp19a1b mRNAs in the brain of 7-dpf
zebrafish larvae exposed or not to bisphenol A (BPA) or
ethinyl estradiol (EE2), a weak and a strong synthetic estrogenic
compounds, respectively. Three different concentrations of BPA
(0.1, 1, or 10 µM) were tested to identify the dose of BPA
allowing the best cyp19a1b gene response, and compared to EE2
(1 nM) or control DMSO-treated larvae To overcome potential
individual variations, we pooled 70 heads in each treatment
group (DMSO, EE2, BPA 10, BPA 1, and BPA 0,1). In all
treatment groups, no toxic or teratogenic effect was identified.
Treated animals survived until 7-days larval stage and were
identical to untreated larvae regarding morphology and motility
(data not shown). After exposure, quantitative RT-PCR on brain
extracts was then performed in triplicate as described inMaterials
andMethods. As shown in Figure 1A, exposure to EE2 induced a
very strong overexpression (over 60-fold) of the cyp19a1b gene
in the brain of 7-dpf larvae, in comparison to control larvae
treated with DMSO only. A weaker induction, compared to EE2,
was detected in larvae exposed to BPA ranging from 0.1 to
10 µM (Figure 1A). Interestingly, BPA concentration of 1 µM
induced about 20-fold cyp19a1b transcripts levels, whereas 0,1,
and 10 µM BPA concentrations had lower effects on cyp19a1b
transcripts (9- and 12-fold inductions, respectively). As BPA was
capable of stronger induction at a 1 µM concentration and did
not caused notable toxicological effects, we therefore selected
this specific concentration to analyze the effects of BPA analogs
in subsequent experiments (RT-qPCR, in situ hybridization and
EASZY assays). This concentration is also either below or similar
to the bisphenols concentrations commonly used in studies on
zebrafish embryos (Sun et al., 2009; Chung et al., 2011; Lam et al.,
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FIGURE 1 | (A) Expression of cyp19a1b gene in 7-dpf larvae brains upon
treatments with EE2 (1 nM) and three different concentrations of BPA (0.1, 1,
or 10 µM). RNA levels were measured in triplicate by real-time quantitative
RT-PCR of total RNA prepared from pooled animals (70 per condition). Fold
induction was expressed relative to the solvent (DMSO); (B) Expression of
cyp19a1b gene in 7-dpf larvae brains upon treatments with EE2, BPA, and
four individual BPA analogs (BPS, BPF, BPAF, and BPAP). For each chemical
the concentration used is 1 µM excepted for EE2 (1 nM) and the vehicle
(DMSO). RNA levels were measured in triplicate by real-time quantitative
RT-PCR of total RNA prepared from pooled animals (70 per condition). Fold
induction was expressed relative to the solvent (DMSO); Data in (B) are
presented as mean ± SEM of six separate egg exposures derived from six
independent spawns. a: p < 0.05 vs. DMSO; b: p < 0.05 vs. EE2.
2011; Staples et al., 2011; Wu et al., 2011; Keiter et al., 2012; Ji
et al., 2013; Saili et al., 2013; Tse et al., 2013; Wang et al., 2013;
Naderi et al., 2014).
Bisphenol A Analogs Induce cyp19a1b
Gene Expression in Wild Type 7-dpf Larva
Brain
The ability of BPA analogs to stimulate or not the expression
of cyp19a1b estrogenic marker gene was then tested in vivo in
the brain of wild type 7-dpf larvae. BPS, BPF, BPAF, and BPAP
were tested at 1 µM on groups of 70 larvae. In addition, BPA (1
µM) and EE2 (1 nM) groups were used as positive controls, and
a DMSO group as a negative control. Due to possible variations
between egg batches, the entire experiment was repeated on
six independent layings using the same standardized exposure
protocols. Importantly, 1 µM treatments of BPA analogs did
not affect the survival rate and the motility of exposed larvae
(data not shown). In addition, no teratogenicity was observed
all along the treatment and prior to the RT-qPCR analysis
(data not shown). Figure 1B shows data obtained in the six
independent experiments along with statistical analysis (Kruskal-
Wallis). We found a general effect of the bisphenol analogs
treatment on aromatase expression (H = 26.95, p < 0.0001).
Dunn’s post-hoc analysis showed a significant cyp19a1b induction
by BPA, BPS, and BPAF in 7-dpf larvae (about 36-, 41-, and 43-
fold induction compared to DMSO-treated larvae, respectively;
Figure 1B). Although BPF exposure lead to an apparent increase
in aromatase expression, this 20-fold up-regulation did not
reach statistical significance. In contrast, BPAP had no effect on
cyp19a1b gene.
In vivo Detection of cyp19a1b Promoter
Activity Using cyp19a1b-GFP Transgenic
Larvae Exposed to Bisphenols
To confirm the results obtained above, we tested the estrogenic
activity of BPA analogs using the cyp19a1b-GFP transgenic
zebrafish line, also named tg (cyp19a1b-GFP) (Tong et al., 2009).
The use of tg (cyp19a1b-GFP) larvae was previously shown to be
a very sensitive and fast assay (EASZY assay) to detect estrogenic
activity (Brion et al., 2012; Petersen et al., 2013; Fetter et al., 2014).
As described in Materials and Methods, experimental groups of
20 transgenic embryos were exposed for 4 days (from 2 h to 4 days
post-fertilization) with 1 µM BPA, BPS, BPF, BPAF, or BPAP. In
addition, control groups of transgenic embryos were exposed to
either EE2 (1 nM) or DMSO alone. Figure 2A shows examples
of the GFP signal generated in the whole brain by the different
bisphenols together with the positive (EE2) and negative (DMSO)
controls. Larvae treated only with DMSO (Figures 2Ag,B) show
a basal GFP fluorescence, equivalent to those treated only
with water (data not show). GFP induction occurs mostly in
the midline of the brain, at the preoptic area level (arrow in
Figure 2Ag). All other GFP fluorescence induction values were
normalized in relation to this signal, considered as the basal
activity of the cyp19a1b promoter (Figure 2B). Quantification of
the signal and one-way ANOVA analysis revealed a significant
overall effect of the treatment [F(6, 85) = 35.43, p < 0.0001].
As expected, exposition of larvae to the synthetic estrogen EE2
(1 nM) strongly increased the GFP fluorescence intensity in the
brain, attesting an important activity of the cyp19a1b promoter
in the presence of EE2 (Figures 2Aa,B). An intense GFP signal
is detected in the radial glial cells together with a much wider
distribution from the telencephalon to the caudal hypothalamus
(Figure 2A, compared Figure 2Aa and Figure 2Ag). As shown in
Figure 2B, there was 31-fold induction of the GFP fluorescence
in EE2-treated animals compared to DMSO-treated animals. The
BPA also significantly increased the GFP fluorescence intensity
(Figures 2Ab,B), albeit to a lower level compared to EE2 (16-fold
induction compared to the DMSO control). Using this in vivo
experiment, we also demonstrated that BPA analogs such as
BPS, BPF, and BPAF also increased the GFP fluorescence in the
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FIGURE 2 | (A) In vivo imaging of 4-dpf old live transgenic cyp19a1b-GFP
zebrafish larvae exposed to EE2, BPA, and various bisphenol A analogs.For
each chemical the concentration used is 1 µM excepted for EE2 (1 nM) and
the vehicle (DMSO). Dorsal views of the brains. Anterior is to the top. Bar = 20
µm. (B) Quantification of GFP fluorescence in zebrafish larvae exposed to the
various compounds. Results are expressed as fold induction above control.
Data re presented as mean ± SEM of 20 specimens per condition (n = 20). a:
p < 0.05 vs. DMSO; b: p < 0.05 vs. EE2, c: p < 0.05 vs. BPA, d: p < 0.05 vs.
BPS, e: p < 0.05 vs. BPF, f: p < 0.05 vs. AF.
brain (Figures 2Ac–e). Quantifications of the GFP signal reveals
that fluorescence intensity for BPAF and BPF (14- and 13-fold
inductions, respectively) was similar to BPA and significantly
higher than the control (Figure 2B). The 6-fold induction by
BPS did not reach statistical significance (Figure 2B). In contrast,
larvae exposed to BPAP did not affect GFP fluorescence signal
(Figures 2A,B). Taken together, these data show a correlation
between the induction of the cyp19a1b promoter activity in the
transgenic zebrafish line (trough measuring GFP fluorescence)
and the cyp19a1b gene expression that we observed in RT-qPCR
analysis in wild type larvae with BPA, BPS, BPF, and BPAF
(Figure 1B). In addition, we also confirm that BPAP did not
significantly induce cyp19a1b gene expression.
Effects of Bisphenols on cyp19a1b
Transcripts Distribution in the Developing
Zebrafish Brain
To analyze a possible change in the distribution of cyp19a1b
transcripts in the brain following bisphenol treatment, we
performed in situ hybridization on serial and thin transverse
sections of wild type exposed larva brains (7-dpf). We first
compared cyp19a1b expression patterns in larvae exposed
to EE2, BPA or DMSO alone. As shown in Figures 3, 4,
cyp19a1b transcripts cannot be detected on thin sections along
the rostral-caudal axis of brains that were only treated with
DMSO (Figures 3, 4A1-K1). In contrast, EE2-treated larvae
show a massive over-expression of the cyp19a1b transcripts in
several and specific regions of the brain, notably in posterior
telencephalon, preoptic area (arrows in Figures 3B2–D2) and
caudal hypothalamus (lateral and posterior ventricular recesses;
arrows in Figures 4G2–J2). Importantly, BPA-treated larvae
also displayed strong presence of cyp19a1b transcripts in
virtually identical regions than EE2-treated larvae (arrows in
Figures 3, 4A3–K3). These in situ hybridization data confirm
and extend previous studies showing that both estrogen and
xenoestrogens increase cyp19a1b RNA levels in these brain
regions (Menuet et al., 2005; Lassiter and Linney, 2007;
Mouriec et al., 2009a; Tong et al., 2009; Chung et al.,
2011).
As the strongest induction of cyp19a1b transcripts along
the rostro-caudal axis of the brain was observed in the caudal
hypothalamus, notably in the area of the nucleus recessus
posterioris (nrp) (Figures 4I2,3), we therefore focused our
analysis on this brain particular region for the assessment
of estrogenic activities of BPA analogs. As shown in the
Figure 5, we confirmed that no cyp19a1b transcript was
detectable in the nrp of DMSO-treated larva (Figures 5A,C),
whereas strong levels of cyp19a1b transcripts were found in
BPA-treated larva (Figures 5B,D). Most importantly, a similar
high detection of cyp19a1b transcripts was also observed in
this hypothalamic region with other bisphenols such as BPS,
BPAF, and BPF (Figures 5E–H). These in situ data are in
perfect agreement with the above RT-qPCR and EASZY assays
(Figures 1, 2). For BPAP-treated larva, there was also an
increase in cyp19a1b transcripts in the nrp region (Figure 5H)
albeit to a lower levels compared to specimens treated with
other bisphenols (BPA, BPS, BPF, and BPAF). Although no
significant increase of cyp19a1b transcripts was observed in
BPAP-treated animals using RT-qPCR and EASZY assays
(Figures 1, 2), we decided to analyze in close details the
distribution of cyp19a1b transcripts in the whole brain of BPAP-
treated larva. As clearly shown in Figure 6, BPAP induces
expression of cyp19a1b transcripts in only a few (xeno) estrogen-
sensitive cyp19a1b expression sites. In particular, cyp19a1b
transcripts were not observed in the anterior regions of the
brain, corresponding to the posterior telencephalon and the
preoptic area (Figures 6B2–E2). For BPS-, BPF-, and BPAF-
treated animals, the cyp19a1b transcripts distribution patterns
in the whole brain were identical to EE2- and BPA-treated
animals, including in brain regions other than the nrp (dat
not shown). Taken together, the absence of cyp19a1b transcripts
in anterior regions of the brain and the weak detection of
cyp19a1b transcripts in the caudal hypothalamus argue and
confirm that BPAP has almost no estrogenic activity in the
brain compared to other tested bisphenols (BPA, BPF, BPAF,
and BPS).
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FIGURES 3, 4 | Distribution of cyp19a1b transcripts in 7-dpf old zebrafish brains after treatments with EE2 (A2–K2) and BPA (A3–K3) and compared to
the DMSO control (A1–K1). Images of transverse sections through the rostrocaudal axis of brains. Arrowheads highlight areas of labeling. For all images, dorsal is to
the top. Scale bar = 50 µm.
Bisphenols Induce cyp19a1b Activity
through Estrogen Receptors in a Glial Cell
Model
To investigate in more detail the mechanism of bisphenols-
induced transcription of cyp19a1b in radial glial cells of the
brain, we performed functional cyp19a1b-luciferase reporter
gene assay in a reconstituted glial cell line model (Le Page
et al., 2006). We tested the impact of each bisphenol on the
transcriptional activity of the three distinct zebrafish estrogen
nuclear receptors (ERα, ERβ1, and ERβ2) transfected inU251MG
cells, an ER-negative human glial cell line. In this assay, the
zebrafish cyp19a1b promoter upstream of the luciferase is used
as the reporter gene. We evaluated trans-activation properties of
the different zebrafish estrogen nuclear receptors (ERα, ERβ1,
and ERβ2) upon individual bisphenol treatments (BPA, BPS,
BPF, and BPAF), EE2 and DMSO in six independent transfection
experiments. As shown in Figure 7A, a priori analysis using a
one-tailed t-test confirmed previous studies (Le Page et al., 2010)
showing a strong induction of the cyp19a1b-luciferase reporter
gene upon EE2 treatments in cells transfected with either ERα
(t = 3.01 df = 10, p < 0.01), ERβ1 (t = 1.927 df = 10, p <
0.05) or ERβ2 (t = 2.495, df = 10, p< 0.05) compared to DMSO
treatment. EE2-dependent activation of the cyp19a1b promoter
was about 2- to 3-fold more efficient with ERα compared to
ERβ1 and ERβ2. No reporter gene activity was found in absence
of estrogen receptors (Figure 7A; empty plasmid), confirming
that the transcriptional activity detected upon EE2 treatment
is mediated by the presence of an estrogen nuclear receptor.
We found a significant effect of the treatment [F(6,82) = 12.69,
p < 0.0001], estrogen receptor subtype [F(3,82) = 24.24, p <
0.0001], and an interaction [F(18,82) = 3.53, p < 0.0001] on
luciferase expression. More precisely, post-hoc analysis revealed
a significant stimulation of cyp19a1b promoter activity by BPA
and BPAF in ERα-containing cells. BPF also increased luciferase
activity in ERα cells, but the stimulation did not reach statistical
significance. In contrast, no significant luciferase activity was
found in cell transfected with subtype receptor ERβ1 or ERβ2
upon stimulation with any bisphenols. Independently of the
estrogen receptor sub-type, BPAP, and BPS did not stimulate the
reporter gene (Figure 7A). To further confirm that stimulation
of cyp19a1b promoter upon BPA, BPF, and BPAF treatments
was mediated by ERα–dependent transcription, we repeated the
transfection experiments with ERα in presence or absence of
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ICI 182 780, an antagonist of estrogen nuclear receptors. As
shown in Figure 7B, simultaneous treatment with ICI completely
abolished BPA, BPF, and BPAF stimulations found in ERα-
expressing cells (Figure 7A). Taken together, the reporter gene
assays in a glial cell context provide evidence that BPA, BPF, and
BPAF are ERα agonists whereas BPS is likely to work through
other mechanisms.
Bisphenols Binding to Zebrafish Estrogen
Nuclear Receptors
Using in vitro competition assays strategy, we examined the
receptor-binding affinity of BPA and BPA analogs (BPS, BPA,
BPF, and BPAF) relative to [3H]17beta-estradiol for the three
in vitro translated zebrafish estrogen receptors (ERα, ERβ1,
and ERβ2). As expected, E2 show a high binding activity
with the three zebrafish estrogen receptors (IC50: 1.5, 1.1, and
1.2 nM for ERα, ERβ1, and ERβ2, respectively; Figures 8A–C).
In perfect agreement with reporter gene assays, we found
that BPA, BPF, and BPAF bind in vitro to ERα receptor
(Figure 8A). BPAF showed the highest affinity, followed by
BPA and BPF (IC50; 0.076, 2.8, 10.6 µM, respectively). In
addition, these receptor-binding activities were clearly reduced
with ERβ1 and ERβ2 sub-type receptors (Figures 8B–C). In
the competition assay with BPAF, the IC50 was almost 10
times stronger for ERβ1 [IC50= 0.66 µM] than for ERα.
Importantly, BPS displayed almost no binding affinities with
any ER receptors (Figures 8A–C). These results suggest that the
weak cyp19a1b-luciferase activity observed in the transfection
experiment for BPS was probably due to the absence of binding
to ERα.
DISCUSSION
The present work investigated the effects of several bisphenol
A analogs on cyp19a1b gene regulation, coding for aromatase
B, a well-known target of (xeno) estrogen signaling pathways
in the fish brain. We show here that BPA, BPS, BPF, and
BPAF are able to up-regulate the aromatase B in the brain of
developing zebrafish, using three different in vivo and in situ
methods, i.e., RT-qPCR, in situ hybridization and the transgenic
cyp19a1b-GFP.
The BPA exposure of zebrafish larvae led to a 36-fold
over-expression of cyp19a1b gene in the brain compared to
control 7-dpf larvae, as demonstrated by RT-qPCR (Figure 1B).
This over-expression was confirmed by the EASZY assay with
which we found a BPA-inducing activity of the cyp19a1b
promoter by quantification of the GFP fluorescence in transgenic
cyp19a1b-GFP brains in 4-dpf larvae (Figure 2B; 16-fold
induction). The level of cyp19a1b induction is in agreement
with previous RT-qPCR experiments carried out on whole
zebrafish larvae that were exposed to BPA between 3 and
4-dpf developmental stages (Chung et al., 2011) and with
previous experiments performed in our laboratory (Brion
et al., 2012). Additionnally, in situ hybridization experiments
on larva brain sections confirmed that BPA caused a strong
expression of the cyp19a1b gene in specific areas of the
FIGURE 5 | In situ expression of cyp19a1b at the level of the caudal
hypothalamus (7-dpf old larvae) after treatments with various BPA
analogs (E–H) and comparison with negative (A,C) and positive (B,D)
controls.
brain, in particular in the hypothalamus (Figures 3–5). Thus,
we show here that the combination of the three different
techniques (RT-qPCR, EASZY assay, and in situ hybridization) is
a valid strategy to investigate estrogenic properties of bisphenol
compounds.
Our study indicates that BPA analogs, BPS, BPAF, and BPF,
stimulate cyp19a1b expression in vivo. Indeed, in larvae treated
with one of these three bisphenols, we observed a clear induction
of the endogeneous cyp19a1b gene expression in the brain of
wild type 7-dpf old zebrafish (Figures 1B, 5) and up-stimulation
of the cyp19a1b promoter in radial glial cells of GFP transgenic
zebrafish larvae (4 dpf; Figure 2). The pattern of up-regulation of
cyp19a1b by the three BPA analogs is similar to the modulation
observed after BPA exposure, and therefore, strongly suggest
that BPS, BPAF, and BPF exert estrogenic effects on developing
zebrafish brain. It is also likely that numerous other estrogen
sensitive responses, in the brain but also in other tissues,
will also be directly affected by the presence of the bisphenol
analogs. Moreover, the up-regulation of brain aromatase will
lead to an elevated local enzymatic activity and therefore,
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FIGURE 6 | Distribution of cyp19a1b transcripts in a 7-dpf old zebrafish brain after treatment with BPAP (A2–H2) and compared to a BPA-treated brain
(A1–H1). Images of transverse sections through the rostrocaudal axis of brains. Arrowheads highlight areas of labeling. For all images, dorsal is to the top. Scale bar =
50 µm.
elevated levels of locally produced endogenous estrogen might
be expected, adding to the direct estrogenic effect of bisphenol.
This abnormal increase in estrogenic activity, considered as
endocrine disrupting activity, will likely affect brain development
at molecular, cellular, organ, and functional levels, as previously
shown for BPA (Kajta and Wojtowicz, 2013; Rochester, 2013;
Leon-Olea et al., 2014; Negri-Cesi, 2015). In utero or perinatal
exposures to BPA in mammals leads to permanent disruptions
in behavior, including increased levels of aggression and anxiety,
and alterations in learning, memory, exploration, and emotional
responsiveness (see for example, refereces Farabollini et al.,
2002; Miyatake et al., 2006; Rubin et al., 2006; Kawai et al.,
2007; Palanza et al., 2008; Tian et al., 2010; Galea and Barha,
2011; Wolstenholme et al., 2011; Xu et al., 2011). There is little
information on potential in vivo effect of BPA analogs on brain
development and function. However, studies at peripheric level
provide evidence that BPA analogs can have adverse effects
by interfering with the endocrine system. For instance, the
balance of sex steroid hormones and normal reproduction was
significantly affected in adult zebrafish following early (Naderi
et al., 2014) or late (adult stage) exposure to BPS (Ji et al., 2013).
In the later study, BPS exposure led to a significant increase
of 17β-estradiol and decrease of testosterone in the plasma of
male zebrafish, and these alterations were accompanied by an
up-regulation of central and peripheral aromatase expression
(both cyp19a1a and cyp19a1b genes). Similarly to BPS, BPAF
exposure can also disrupt sex hormone levels and vitellogenin
expression in zebrafish (Yang et al., 2014) and, in adult male
rats, BPAF was associated with testosterone reduction by directly
affecting testis function (Feng et al., 2012). In human fetal testis
explants, low dose of BPS, or BPF is also sufficient to decrease
basal testosterone secretion (Eladak et al., 2015). In the brain,
it was recently shown that low-dose exposure to BPA and BPS
might cause hyperactivity and brain changes in the developing
zebrafish due to precocious hypothalamic neurogenesis (Kinch
et al., 2015). Interestingly, such brain effects were paralleled
with an increase of cyp19a1b expression. In C. elegans, BPA,
and BPS exposure during early embryogenesis also affect neural
functionality at adult stage (Mersha et al., 2015) and, in juvenile
female rats, BPA, BPF, and BPS can affect 5α-reductase expression
and dopamine-serotonin innervations in the prefrontal cortex
(Castro et al., 2015).
The preoptic area and the hypothalamus are key integrative
centers in the brain that play pivotal functions in the
neuroendocrine regulation of homeostasis, reproduction, sexual
behavior and stress response (Zohar et al., 2010 and references
therein). The detailed analysis of the distribution of cyp19a1b
transcripts on thin serial sections corresponding to the
whole brain (7 dpf) provided evidence that exposure to
xenoestrogenes, such as BPA or EE2, strongly induced expression
of cyp19a1b transcripts in specific brain regions, including
posterior telencephalon, preoptic area and caudal hypothalamus
(Figures 3, 4). Increase in cyp19a1b promoter activity in these
specific brain regions was also detected in transgenic larvae
(EASZY assays; Figure 2). The different brain regions where
cyp19a1b was upregulated following bisphenol exposure were
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FIGURE 7 | (A) Cyp19a1b-luciferase assay in a glial cell context expressing either ERα, ERβ1, or ERβ2. Luciferase activity was measured in triplicate for each
condition following treatment with EE2 or bisphenol analogs. Data are presented as mean ± SEM of five independent cellular treatment experiments. a: p < 0.05 vs.
DMSO in ERα–containing cells; b: p < 0.05 vs. EE2 in ERα-containing cells; c: ERα vs. BPA. (B) Cyp19a1b-luciferase assay in a glial cell context expressing the ERα
sub-type in presence or absence of ICI. Luciferase activity was measured in triplicate for each condition.
previously identified as sites of estrogen-induced cyp19a1b
expression (Menuet et al., 2005; Lassiter and Linney, 2007; Tong
et al., 2009; Mouriec et al., 2009a; Chung et al., 2011). In
addition, we demonstrated that the caudal hypothalamus, and
more precisely the lateral and posterior ventricular recesses (nrp),
contains the highest amount of cyp19a1b transcripts after BPA or
EE2 exposures. Importantly, BPS, BPF and BPAF were also able
to strongly induce cyp19a1b expression in the nrp in the caudal
hypothalamus, with a similar intensity compared to BPA and EE2
(Figure 5). Since various xenoestrogens can strongly stimulate
cyp19a1b expression in similar and specific brain regions, this
raise concern about the consequences of their combined actions
on hypothalamic development and functioning.
Three distinct nuclear estrogen receptors (zfER) are
characterized in zebrafish: ERα, ERβ1, and ERβ2, corresponding
to esr1, esr2b, and esr2a, respectively. The three receptors can
bind estradiol and are strongly expressed in the anterior and
posterior preoptic area, and in the caudal hypothalamus (Menuet
et al., 2002). As shown in this study, these two neuroendocrine
regions are also the major sites of bisphenol-induced cyp19a1b
expression (Figures 3–6). To define which estrogen receptors
was implicated in the up-regulation of cyp19a1b gene, we used
zebrafish cyp19a1b promoter luciferase reporter gene assay in
a reconstituted glial cell context expressing one zebrafish ER
subtype at a time (as previously reported (Menuet et al., 2005;
Le Page et al., 2006). We showed here that BPA, used at a 10−6
M concentration, activates cyp19a1b promoter via its interaction
with ER alpha, while the presence of either ER beta subtypes
does not allow BPA to activate the promoter. BPF and BPAF are
also able to stimulate in vitro the cyp19a1b promoter activity
via the activation of ERα. This up-regulation was inhibited by
the presence of the specific estrogen receptor antagonist ICI 182
780. (Figure 7). In vitro ligand competition assays confirmed
that BPF and BPAF, in addition to BPA, physically bind zebrafish
estrogen receptor alpha (Figure 8). Previous in vitro studies
(reporter gene and ligand binding assays) performed in other
cellular models also showed the ability of BPF and BPAF to
act as an estrogen mimic that binds to estrogen receptors and
subsequently exert trans-activation activities (Kitamura et al.,
2005; Cabaton et al., 2009; Matsushima et al., 2010; Li et al.,
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FIGURE 8 | In vitro bisphenols-and E2-binding activity to zebrafish
estrogen receptors. (A–C) Competitive binding assays relative to
[3H]17β-estradiol on ERα (A), ERβ1 (B), and ERβ2 (C). Binding activity was
measured in triplicate for each condition and data are presented as mean ±
SEM of these 3 radioactivity countings. IC50 are provided in the Results
section.
2012). In yeast assays, estrogenic activity for these BPA analogs
was also reported (Hashimoto et al., 2001; Ruan et al., 2014).
As stated above, we showed that BPS significantly stimulated
the expression of cyp19a1b in vivo but, interestingly, this
effect did not involve the bisphenol-dependent activation of
estrogen receptors in our cyp19a1b-luciferase reporter gene in the
functional glial cell assay (Figure 7). This is in stark contrast with
the data obtained with BPA, BPF, and BPAF, acting on cyp19a1b
up-regulation via ERα subtype (Figure 7). It is possible that BPS
has only a very weak affinity for the zebrafish estrogen receptors.
This hypothesis was clearly reinforced by the ligand competition
assays that showed almost no binding activity for BPS compared
to other tested bisphenols (Figure 8). Previous in vitro studies
have shown for BPS, lower (Chen et al., 2002; Kitamura et al.,
2005; Rosenmai et al., 2014), similar (Hashimoto et al., 2001;
Kitamura et al., 2005; Kuruto-Niwa et al., 2005; Grignard et al.,
2012; Kang et al., 2014), or higher (Molina-Molina et al., 2013)
estrogenic activity than BPA, depending on the experimental
model. In the reporter gene assay, the lack of estrogenic activity
for BPS could be linked to the absence of key transcriptional co-
factors required for efficient estrogen receptor-dependent trans-
activation. Alternatively, in vivo BPS-induced estrogenic activity
could be mediated through a different pathway than estrogen
receptors. BPS acts as an estrogen mimic in certain conditions,
but can also antagonize androgen receptor (Hashimoto et al.,
2001; Kitamura et al., 2005; Kuruto-Niwa et al., 2005; Grignard
et al., 2012). Recent in vitro studies provide evidence that BPA
analogs have a clear effect on androgen receptor activity as well as
on steroid hormone synthesis (Rosenmai et al., 2014), suggesting
that these compounds may interfere with the endocrine system
through several modes of action. In addition, in the case of BPAF
and in human breast cells, estrogenic activity has been proven
to be mediated through both genomic (ERα) and nongenomic
pathways (Li et al., 2014).
We did not observe a significant induction of the expression
of cyp19a1b gene expression in the brain of larvae treated with
BPAP, using RT-qPCR and EASZY strategies (Figures 1, 2).
These data were confirmed in the glial cell context cyp19a1b-
luciferase reporter gene assay (Figure 7). The detailed analysis
of cyp19a1b transcripts distribution carried out in the whole
brains of BPAP-treated larvae revealed that cyp19a1b transcripts
were, indeed, not detected in telencephalon or preoptic area
and very weakly in the caudal hypothalamus (Figure 6). Taken
together, these data suggest that BPAP might have no or a
very weak estrogenic activity in the brain in vivo, compared
to other bisphenols tested here (BPA, BPS, BPF, and BPAF).
To the best of our knowledge, there is only one study that
reports low estrogenic activities for BPAP in a recombinant gene
yeast assay (Zhang et al., 2009). Our data suggest that BPAP
might be a safer alternative to BPA and to other BPA analogs
currently used. Presently, BPAP use in industry is not (yet) a
common BPA substitute as its environmental concentrations,
as measured in food or in indoor dust, is very low compared
to other bisphenols (Liao et al., 2012b; Liao and Kannan,
2013).
In conclusion, this work shows that BPA, BPF, BPAF, and BPS
exhibit estrogenic activity on the cyp19a1b gene (aromatase B),
a brain specific gene, which is considered as one of the most, if
not the most, E2-sensitive gene in fish (Brion et al., 2012; Lee
et al., 2012; Petersen et al., 2013). Thus, BPA analogs, because
of their widespread use and their potential to persist in the
environment, may be equally as harmul as BPA to developing
brains. In contrast, BPAP appears to have no estrogenic activity
in the brain of zebrafish. To confirm that BPAP could be a
safer alternative to BPA, studies investigating its effects on other
tissues and signaling pathways will be required. A replacemant
of BPA by any of these coumpounds should be considered with
caution and further studies are clearly required to clarify the
precise in vivo effects of BPA analogs and their mechanisms of
actions.
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